Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+5.9%
5Y CAGR+17.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+5.9%/yr
vs +18.8%/yr prior
5Y CAGR
+17.2%/yr
Recent deceleration
Acceleration
-12.9pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.38M | -55.6% |
| 2024 | $25.64M | +119.3% |
| 2023 | $11.69M | +21.9% |
| 2022 | $9.59M | +46.6% |
| 2021 | $6.54M | +27.1% |
| 2020 | $5.15M | +3.1% |
| 2019 | $4.99M | +3.6% |
| 2018 | $4.82M | +16.6% |
| 2017 | $4.14M | -12.0% |
| 2016 | $4.70M | - |